| G1 < 2 H/Y | G2 ≥ 2 H/Y | P |
Age (years) | 67.6 | 66.9 | 0.31 |
Gender (Male,%) | 96.7 | 97.1 | 0.79 |
BMI (kg/m2) | 24.04 | 23.83 | 0.61 |
Comorbidities ≥ 1 (%) | 87 | 85.3 | 0.45 |
Cardiovascular comorbidities (%) | 38.9 | 44.1 | 0.11 |
Diabetes | 14.4 | 19.6 | 0.032 |
Smoking status: Current or ex-smokers (%) |
96.1 |
98.3 |
0.26 |
mMRC ≥ 2 (%) | 56 | 87 | <10-3 |
FVC (L) | 1.91 | 1.62 | <10-3 |
FEV1 post β2 (L) | 1.24 | 0.97 | <10-3 |
FEV1/FVC post β2 (%) | 58.4 | 54.5 | <10-3 |
Mean FEV1 decline (ml/year) | 56 | 65 | 0.035 |
PaO2 (mmHg) | 70.2 | 63.5 | <10-3 |
PaCO2 (mmHg) | 40.4 | 43.2 | <10-3 |
N of AE/year | 2.1 | 4.7 | <10-3 |
AE due to Pyocyanic (%) | 4 | 15.4 | <10-3 |
Chronic respiratory failure (%) | 48 | 75 | <10-3 |